Anteris Technologies Global Corp. — Capital/Financing Update 2010

Apr 6, 2010

==> picture [596 x 63] intentionally omitted <==

Innovative BioMedical Devices

Level 11, 225 St Georges Terrace bioMD Limited ABN 35 088 221 078 Perth, Western Australia 6000 PO Box 7209, Cloisters Square Western Australia 6850

Telephone (08) 9262 6777 Facsimile (08) 9322 3433

www.biomd.com.au

ANNOUNCEMENT TO THE AUSTRALIAN STOCK EXCHANGE

1 of 1 page

7 April 2010

Company Announcements Office Australian Stock Exchange Limited 10[th] Floor, 20 Bond Street SYDNEY NSW 2000

Dear Sir/Madam

PRO RATA NON-RENOUNCABLE RIGHTS ISSUE

The Directors of Australian biotechnology company, bioMD Limited (ASX: BOD), are pleased to announce the Non Renounceable Rights Issue of Options that closed on 31 March 2010 raised a total of $581,837 for the issue of 38,789,168 Options. This represents a 45.2% takeup of options offered to shareholders registered on the record date.

The shortfall from the issue is 47,092,907 options. Pursuant to the terms of the Entitlement Issue Offer Document dated 25 February 2010 and the Underwriting Agreement with Bell Potter Securities Limited, the Shortfall will be allocated to sub-underwriters. Upon completion of the underwriting, a total of $1.288 million will be raised.

The Company is appreciative of the support of its shareholders in this Offer.

Yours faithfully

==> picture [79 x 60] intentionally omitted <==

Caroline Bentley Company Secretary

==> picture [596 x 42] intentionally omitted <==